Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
Big Pharma CEOs get candid about pricing and M&A
Pharma Voice
Mon, 07/31/23 - 10:03 am
Big Pharma
Pharma CEOs
drug pricing
M&A
JNJ
Merck
GSK
Alkermes, nearing oncology split, posts big Q2 sales gain after winning J&J arbitration case
Fierce Pharma
Wed, 07/26/23 - 06:37 pm
JNJ
Alkermes
oncology
earnings
J&J, GSK's ViiV tout switching study showing patients prefer their long-acting HIV med Cabenuva over Gilead rival
Fierce Pharma
Tue, 07/25/23 - 09:20 pm
JNJ
GSK
ViiV
Gilead Sciences
HIV
Cabenuva
Biktarvy
J&J outlines exchange offer for Kenvue shares
Medical Marketing and Media
Mon, 07/24/23 - 09:39 pm
JNJ
Kenvue
shareholders
Pfizer, Gilead, GSK to Capture Growing Infectious Diseases Market as J&J Pulls Back
BioSpace
Mon, 07/24/23 - 10:26 am
infectious diseases
Pfizer
Gilead Sciences
GSK
JNJ
J&J’s 2Q23 Results Show It’s a Force to Be Reckoned with in Medtech
Medical Devices and Diagnostics Industry
Sun, 07/23/23 - 12:40 pm
JNJ
Medtech
earnings
J&J flags potential interference between heart pump and TAVR stents in recall
Medtech Dive
Fri, 07/21/23 - 11:56 am
JNJ
Abiomed
TAVR
Impella
device recalls
Medtech
J&J Exceeds Q2 Expectations, Oncology and Immunology Top Pharma Drivers
BioSpace
Thu, 07/20/23 - 09:51 pm
JNJ
earnings
Janssen’s newly-merged infectious disease and vaccine unit sees significant pipeline cuts
Fierce Biotech
Thu, 07/20/23 - 10:18 am
JNJ
Janssen
infectious disease
vaccines
hepatitis
HIV
Abiomed’s Impella System Hit with Another Recall
Medical Devices and Diagnostics Industry
Wed, 07/19/23 - 05:47 pm
JNJ
Abiomed
Impella
TAVR
device recalls
Medtech
J&J ordered to pay mesothelioma patient $18.8M in talc case, pledges to appeal
Fierce Pharma
Wed, 07/19/23 - 11:46 am
JNJ
legal
mesothelioma
House Judiciary Committee Probes Big Pharma’s Potential Role in COVID-19 Censorship
BioSpace
Wed, 07/19/23 - 10:23 am
Pfizer
JNJ
Merck
Big Pharma
COVID-19
US Congress
Johnson & Johnson becomes 4th drugmaker to file suit against IRA's drug price negotiations
Fierce Pharma
Tue, 07/18/23 - 10:07 pm
JNJ
drug pricing
Inflation Reduction Act
J&J touts Rybrevant win in newly diagnosed lung cancer, with key Tagrisso head-to-head readout up next
Fierce Pharma
Mon, 07/17/23 - 07:04 pm
JNJ
Rybrevant
non-small cell lung cancer
Takeda
Tagrisso
See which pharma brands are the strongest and fastest-growing in 2023
Medical Marketing and Media
Wed, 07/12/23 - 11:12 pm
JNJ
Pfizer
CSL
branding
J&J's Ethicon Faces Mega Electrode Recall
Medical Devices and Diagnostics Industry
Wed, 07/12/23 - 09:26 am
Medtech
JNJ
Ethicon
electrodes
device recalls
electrosurger
Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal
Medical Marketing and Media
Tue, 07/11/23 - 11:27 pm
JNJ
Janssen
Nanobiotix
NBTXR3
soft tissue sarcoma
Hensify
J&J Extends Lifeline to Nanobiotix in Potential $1.8B Licensing Deal
BioSpace
Mon, 07/10/23 - 09:36 pm
JNJ
Nanobiotix
NBTXR3
radiotherapy
head and neck cancer
Janssen’s trial of plaque psoriasis therapy meets endpoints
Clinical Trials Arena
Wed, 07/5/23 - 10:18 am
Janssen
JNJ
clinical trials
JNJ-2113
plaque psoriasis
Former J&J sales rep indicted on charges of defrauding Boston hospital
Medtech Dive
Thu, 06/29/23 - 11:37 am
Medtech
fraud
JNJ
DePuy Synthes
legal
Boston
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »